{"id":"da-5212","safety":{"commonSideEffects":[{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Flushing"},{"rate":null,"effect":"Dyspepsia"},{"rate":null,"effect":"Hypotension"}]},"_chembl":{"chemblId":"CHEMBL580314","moleculeType":"Small molecule","molecularWeight":"420.54"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"By inhibiting PDE5, DA-5212 increases cyclic GMP levels in vascular smooth muscle, leading to vasodilation and improved microcirculation. This mechanism is intended to enhance tissue oxygenation and promote healing in conditions characterized by impaired blood flow or ischemic injury.","oneSentence":"DA-5212 is a selective inhibitor of phosphodiesterase 5 (PDE5) that enhances nitric oxide signaling to improve blood flow and tissue perfusion.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:08:25.801Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Diabetic foot ulcers"},{"name":"Chronic wounds and tissue regeneration"}]},"trialDetails":[{"nctId":"NCT05842408","phase":"PHASE3","title":"Clinical Trial of DA-5212 in Patients with Functional Dyspepsia","status":"COMPLETED","sponsor":"Dong-A ST Co., Ltd.","startDate":"2023-06-06","conditions":"Functional Dyspepsia","enrollment":384}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"DA-5212","genericName":"DA-5212","companyName":"Dong-A ST Co., Ltd.","companyId":"dong-a-st-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"DA-5212 is a selective inhibitor of phosphodiesterase 5 (PDE5) that enhances nitric oxide signaling to improve blood flow and tissue perfusion. Used for Diabetic foot ulcers, Chronic wounds and tissue regeneration.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}